Outcomes and Cosmesis With Whole Breast Irradiation and Boost
ConditionEarly-stage Breast Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorUniversity of Wisconsin, Madison
About this trial
This study is being done to evaluate cosmetic, patient-reported outcome measures (PROMs), and toxicities for women undergoing ultra-short whole breast irradiation (WBI) therapy with simultaneous integrated boost (SIB). 50 participants will be on study for up to 60 months.
Eligibility criteria
Qualifiers
Ability to understand and the willingness to sign a written informed consent document
Histologically confirmed early stage (stage T1-T2) invasive carcinoma of the breast or DCIS
Breast conserving surgery with negative margins and negative nodes (surgical axillary staging not mandatory), stage N0 or Nx
Treatment plan should include breast conserving surgery and adjuvant whole breast irradiation (WBI) therapy delivered with 3D-CRT or IMRT techniques
Disqualifiers
Mastectomy of ipsilateral breast
Lack of histologic diagnosis
Histologic involvement of the axillary or regional nodes or metastatic disease
Accelerated partial breast irradiation treatment plan
Trial design
Treatments tested in this trial
- Radiation Therapy
Treatment groups
50 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov